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Brief Communication
Glutamate Transporters Prevent the Generation of Seizures
in the Developing Rat Neocortex
Michael Demarque, Nathalie Villeneuve, Jean-Bernard Manent, He´le`ne Becq, Alfonso Represa, Yehezkel Ben-Ari, and
Laurent Aniksztejn
Institut de Neurobiologie de la Me´diterrane´e/Institut National de la Sante´ et de la Recherche Me´dicale U29, Parc Scientifique de Luminy, 13009 Marseille,
France
Glutamate transporters are operative at an early developmental stage well before synapse formation, but their functional significance has
not been determined. We now report that blockade of glutamate transporters in the immature neocortex generates recurrent NMDA
receptor-mediated currents associated with synchronous oscillations of [Ca 2]i in the entire neuronal population. Intracerebroventric-
ular injections of the blocker to pups generate seizures that are prevented by coinjections of NMDA receptor blockers. Therefore, the early
expression of glutamate transporters plays a central role to prevent the activation by local glutamate concentrations of NMDA receptors
and the generation of seizures that may alter the construction of cortical networks. A dysfunction of glutamate transporters may be a
central event in early infancy epilepsy syndromes.
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Introduction
In the adult brain, high-affinity Na-dependent glutamate trans-
porters control the concentration of glutamate in the synaptic
cleft and terminate its actions (Danbolt, 2001). A tight control of
the extracellular concentration of glutamate is of critical impor-
tance because an appropriate level of the transmitter is required
for several physiological processes such as induction of synaptic
plasticity (Katagiri et al., 2001), whereas its accumulation is po-
tentially excitotoxic (Olney et al., 1969) and may generate epilep-
tic seizures (Tanaka et al., 1997; Meldrum et al., 1999). In addi-
tion, by preventing diffusion of glutamate to distal sites,
glutamate transporters enable a topic inflow of information and
limit the activation of other excitatory synapses and a cooperative
interaction between excitatory synapses (Diamond, 2001; Arnth-
Jensen et al., 2002). Glutamate transporters also contribute to the
synthesis of GABA via the supply of glutamate to GABAergic
terminals (Sepkuty et al., 2002; Mathews and Diamond, 2003)
A very different situation prevails in the immature brain. Glu-
tamate transporters are functional at an early stage when there are
little or no synaptic connections (Juraska and Fifkova, 1979; Blue
and Parnavelas, 1983a,b; Furuta et al., 1997; Owens and Krieg-
stein 2001; Demarque et al., 2002), suggesting that they may serve
other roles than the modulation of synaptic transmission. In
keeping with this, glutamate receptors, in particular NMDA re-
ceptors, are operative on migrating neurons that have no synaptic
connections, and their activation or blockade modulate the speed of
migration (Komuro and Rakic, 1993). To gain further insights on
the function of glutamate transporters, we have now studied the
effects of transporters blockade on the activity of immature neocor-
tical neurons. We report that the application of the selective gluta-
mate transporters inhibitor DL-threo--benzyloxyaspartate (DL-
TBOA) generates in immature neocortical slices large NMDA
receptor-mediated currents and [Ca2]i oscillations in the entire
neuronal population. A similar intracerebroventricular application
to pups generates NMDA receptor-mediated seizures. Therefore, a
disruption of glutamate transport may play a central role in the high
incidence of seizures during childhood and infancy.
Materials and Methods
Wistar rats obtained from the day of birth [postnatal day (P) 0] to P5
were anesthetized with chloral hydrate, then decapitated, and brains were
removed rapidly and placed in oxygenated ice-cooled artificial CSF
(ACSF) with the following composition (in mM): 126 NaCl, 3.5 KCl, 2
CaCl2, 1.3 MgCl2, 25 NaHCO3 1.2 NaHPO4, and 10 glucose (95% O2 and
5% CO2, pH 7.4). Transverse neocortical slices (350 – 400 m) were
obtained with a vibratome (Micron HM 650V, Walldorf, Germany) and
kept in oxygenated ACSF at room temperature at least 1 hr before use.
Individual slices were then transferred to the recording chamber, where
they were fully submerged and superfused with ACSF at 32–34°C at a rate
of 2–3 ml/min.
Neurons were recorded under visual control with an axioscope (Zeiss,
Oberkochen, Germany) or a DM LFS microscope (Leica, Nussloch, Ger-
many) using the patch-clamp technique in the whole cell-configuration.
Microelectrodes had a resistance of 5–10 M and filled in the majority of
the experiments with a solution containing (in mM): 120 KM2SO4, 20
KCl, 0.1 CaCl2, 1.1 EGTA, 10 HEPES, 4 Mg
2ATP, and 0.3 NaGTP, pH
7.25; 270 –280 M. QX-314 was sometime added to the pipette solution
to intracellularly block voltage-dependent Na channels. Some experi-
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ments have been performed with a CsCl-filled
pipette solution (in mM): 120 CsCl, 10 CsGlu,
0.1 CaCl2, 1.1 EGTA, 10 HEPES, 4 Mg
2ATP,
and 0.3 NaGTP. Whole-cell measurements in
the voltage-clamp or current-clamp mode were
filtered at 3 kHz using an EPC-9 amplifier
(Heka Elektronik, Lambrecht, Germany). All
data were digitized (1–2 kHz) with a digidata
(Axon Instruments, Foster City, CA) interface
card to a personal computer and analyzed with
a minianalysis program (Synaptosoft). To ob-
tain a current–voltage curve (I/V ), voltage
ramps were applied for 2 sec from 70 to 20
mV. The I/V curves of slow oscillations (SOs)
were constructed by subtracting the ramp re-
sponse in control from that during the maximal
current response. Extracellular recordings were
performed with a glass pipette (1 M) filled
with ACSF and placed in the same layer as the
patch electrode, and the signal was recorded
with a DAM80 amplifier (WPI).
Similar solutions and procedures were used for
experiments performed on the entire neocortex,
although the perfusion was increased to 8–10 ml/
min (for more details, see Khalilov et al., 1997).
Patch-clamp and extracellular recordings were
performed with electrodes positioned at a depth
of 150–200m from the surface.
In vivo experiments. Injection of TBOA was
performed in P5 rats anesthetized with domitor
(0.5 mg/kg; Orion Pharma, Espoo, Finland).
The animal was then placed in a stereotaxic
frame, and 0.5–1 l of TBOA (20 ng/l) was
injected in the right lateral ventricle with a nee-
dle via a peristaltic pump (250 nl/min; WPI) at
stereotaxic coordonates adapted from the atlas
of Paxinos et al. (1991): anterior, 1; lateral,
1.8; H,2.5. The animal was awakened with
the antidote antisedan (1.25 mg/kg; Orion
Pharma). The animal was immediately awak-
ened after the injection of the antidote.
Ca2 imaging. Cells were loaded with the
Ca 2 indicator dye Fura-2 by bath application
of Fura-2AM (Molecular Probes, Eugene, OR).
For AM loading, slices were incubated in a small
vial containing 2.5 ml of oxygenated ACSF with
25 l of Fura2-AM (1 mM) solution (in 100%
dimethylsulphoxyde; Molecular Probes) for
20 –30 min. Slices were incubated in the dark, and incubation solution
was maintained at 35–37°C. Fura-2-loaded slices were transferred to a
recording chamber on the stage of a fluorescent upright microscope
(Axioscope; Zeiss) equipped with a 380 nm excitation filter. Recordings of
[Ca2]i were imaged with 40 water immersion objectives at 32–34°C.
Loaded slices were excited by an UV lamp connected to a personal computer
at a rate of 0.5 Hz using Axobench software (Axon Instruments) at a wave-
length of 380 nm. Fluorescent-emitted were collected through a reflecting
pathway by an UV camera (Till Photonics). Images were analyzed on line
with Axobench software. Pseudocolor images were coded so that blue indi-
cated high level and red indicated low level of Ca2. For each image, fluo-
rescence intensity (F) was averaged over a delimited area of the soma.
Changes in the fluorescence (F) were measured as changes in baseline
fluorescence and expressed as: %F/F [(Fpost Frest)/] 100.
Results
The experiments were performed on layer IV–V pyramidal cells
in neocortical slices from P0 –P5 rats. At that stage, synaptic con-
nectivity is poorly developed (Juraska and Fifkova, 1979; Blue
and Parnavelas, 1983a,b). Nevertheless, as described previously,
spontaneous activity comprised spontaneous fast postsynaptic
currents (PSCs) with a frequency of 0.95 0.35 Hz (n 50) that
were sensitive to glutamatergic and GABAergic receptors antag-
onists (for review, see Owens and Kriegstein, 2001).
DL-TBOA (30 M) was used to reduce the activity of the main
glutamate transporters present in the neocortex of postnatal rat
pups: the neuronal EAAC1 and glial GLT1 and glutamate-
aspartate transporter (GLAST) transporters (Furuta et al., 1997,
Ullensvang et al., 1997). TBOA has several advantages compared
with other glutamate transporters inhibitors: (1) it is a nontrans-
portable inhibitor and, thus, does not induce an artificial release
of the transmitter through hetero-exchange; and (2) it does not
act as a partial glutamate receptor agonist (Shimamoto et al.,
1998; Jabaudon et al., 1999).
Blockade of glutamate transporters generates
synchronized SOs
Bath application of TBOA (30 M) generated within a few sec-
onds (126  23 sec) slow current oscillations (in the voltage-
clamp mode) or depolarizations associated with action potentials
Figure 1. TBOA generates SOs mediated by NMDA receptors. A1, Whole-cell recording of a P3 pyramidal neuron from layer V of
the somatosensory cortex combined with an extracellular recording of the same layer. Bath application of TBOA (30M) generates
current oscillations (top trace) or voltage oscillations (middle trace) that are associated with extracellular activities (E.C.; bottom
trace). SOs did not persist after the washout of TBOA and reappeared with additional application of the blocker. A2, Magnification
of SOs indicated by letters in A1. B, Relationship of SOs to the voltage (I/V ). Voltage ramps were performed from70 to 20 mV
(with a pipette filled with KM2SO4 plus QX-314 to block action potential in the recorded cell) before and at the peak of SOs (top
trace). The graph represents the difference of the two I/V curves (indicated by numbers). C, Representative histogram in which the
number of synaptic events was plotted versus time. D-APV (80M) blocks the SOs and the associated increase in the frequency of
synaptic events. D, Long-lasting inward current induced by TBOA (100M). E, Pyramidal neuron recorded in the current-clamp
mode (the pipette contained QX-314) from another experiment showing that the long-lasting depolarization generated by 100
M TBOA is sensitive to APV.
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(in the current-clamp mode) in 44 of 50 cells (Fig. 1A). SOs
presented the following features: mean amplitude of 99 16 pA
(in the voltage-clamp mode at Vh  65 mV); mean duration,
21  2 sec (range, 5–70); mean oscillation frequency, 0.015 
0.003 Hz. They were associated with a large significant increase in
the frequency of PSCs (14.3 1.8 Hz; p 0.001; ANOVA) (Fig.
1A,C). SOs washed out when TBOA application was stopped and
reinstated with additional applications. When recorded with ex-
tracellular field electrodes, the frequency of events within SOs
ranged between 7 and 30 Hz (mean, 15.8  3 Hz; n  20) (Fig.
1A), indicating that the blockade of glutamate transporters syn-
chronized the activity of immature neurons in a theta–low
gamma range. SOs were network driven as they were blocked by
TTX (1 M) (n  11 of 11; data not shown) but not by QX-314
the intracellular Na channel blocker Lower concentrations of
TBOA (10 M) did not generate SOs, whereas higher concen-
trations of TBOA (	100 M) to fully block transporters (Shi-
mamoto et al., 1998) generated one or two oscillations, followed
by a long-lasting NMDA-mediated inward current (n 11) (Fig.
1D,E). These effects were prevented by the addition of Cd 2
(100 –200M), the voltage-dependent Ca 2 blocker (n 7 of 7),
suggesting that these actions are mediated by transmitter release
and not by a direct activation of NMDA receptors. In keeping
with this observation, applications of NMDA generates a current
in the presence of Cd 2 (n 4 of 4; data not shown). Therefore,
TBOA generates network-driven oscillations in a dose-
dependent manner.
To further emphasize that SOs are generated by a synchro-
nous activation of cortical neurons, we then performed Ca 2
imaging to visualize the activity of individual neurons simulta-
neously. Slices were incubated with the Ca 2-sensitive dye
Fura2-AM, and fluctuations of [Ca 2]i levels were monitored
simultaneously with patch-clamp recordings of neurons. As
shown in Fig. 2, application of TBOA induced a synchronous rise
in [Ca 2]i in all imaged cells. These calcium events were synchro-
nous with the SOs recorded in the voltage-clamp mode or
current-clamp mode (n 4 of 4 slices). Therefore, partial block-
ade of glutamate transporters periodically synchronizes cortical
neuron activity.
SOs are mediated by NMDA receptors
The following observations indicate that SOs are mediated by
NMDA receptors: (1) D-APV (80M), a specific NMDA receptor
antagonist, blocked the oscillations observed in intracellular, as
well as in extracellular, recordings or in Ca 2 imaging (Figs. 1C,
2B) (n  5); and (2) the current-voltage relationship of SOs
showed a region of negative slope at hyperpolarized membrane
potentials and reversed polarity close to 0 mV (3 2 mV; n 5)
(Fig. 1B). However, AMPA/kainate receptors were also involved
in their generation because SOs were blocked by the AMPA/
kainate receptor antagonist CNQX (20 M) (n  5; data not
shown). In contrast, the GABAA receptor antagonist bicuculline
(50 M) blocked neither SOs nor the associated Ca 2 rise, sug-
gesting that GABAA receptors do not contribute to their genera-
tion (n 5; data not shown).
Bath application of NMDA generates oscillations
If SOs are triggered by the activation of glutamate receptors, then
bath applications of their agonists would produce similar effects.
Bath application of NMDA (10M) generated current or voltage
oscillations, albeit with a higher frequency (0.43 0.07 Hz; n
15) and smaller duration and amplitude (2 0.4 sec and 48.9
18.3 pA; n  15) than SOs (Fig. 3A,B). These oscillations were
generated by the synchronous activation of neurons as demon-
strated by the presence of concomitant extracellular field activity.
These oscillations were mediated by glutamate receptors as they
reversed polarity at 0 mV (Fig. 3C) and were blocked by APV or
CNQX but not by bicuculline (Fig. 3D). Moreover, as SOs, these
oscillations were driven by the network because they were
blocked by TTX (Fig. 3E). NMDA failed to generate oscillations
at lower concentrations (3M), whereas higher concentrations of
NMDA (30 M) generated a large inward current without intra-
cellular and extracellular field oscillations (Fig. 3A). This was
reminiscent of the results obtained with TBOA and suggested
that the synchronization of cortical network activity required
appropriated levels of NMDA receptor activation. Applications
of AMPA (1–3 M), kainate (100 –300 nM), and ()-1-
Aminocyclopentane-trans-1,3-dicarboxylic acid (100 –200 M),
which activate AMPA, kainate, and metabotropic glutamate re-
ceptors, respectively, did not generate any oscillation even when
applied together (n 15; data not shown). Altogether, these data
reinforce the predominant role played by NMDA receptors in
TBOA-induced SOs.
Figure 2. SOs are associated with an APV-sensitive synchronous rise of [Ca 2]i in pyramidal
neurons. A, Fura-2AM Ca 2 imaging of layer V of a P5 somatosensory cortex. The three images
(objective, 40) correspond to the Fura-2 Ca 2 imaging before an oscillation ( a), at the peak
of the oscillation ( b), and at the end of the oscillation ( c). B, Traces of the time course of the
fluorescence intensity of the four cells selected by numbers and concomitant with the whole-
cell recording of a pyramidal neuron (in the same layer but out of focus) in the voltage clamp and
current clamp. Ca 2 rise is shown as a decrease in the fluorescence.
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TBOA generates SOs in the intact
neocortex in vitro and seizures in pups
To determine whether SOs were region
specific, we used the intact neocortex
preparation developed by Khalilov et al.
(1997) (Fig. 4A). Bath applications of
TBOA (30 M) generated SOs in the fron-
tal, parietal, and occipital cortices with
similar features as those recorded in slices
[inter-SO frequency, 0.011  0.001 Hz;
duration, 18  3 sec (range, 7–54); fre-
quency of events within the SOs, 15 2 Hz
and full blockade by APV; n  8) (Fig.
4B1). There is no preferential generating
site because SOs could be initiated in any
cortical region (Fig. 4B2). Therefore, the
networks present in any region of the neo-
cortex are capable of generating SOs that
may propagate to other regions.
Finally, we tested the effects of intrace-
rebroventricular injection of TBOA to
pups to determine the consequences of re-
ducing transporters activity in freely mov-
ing animals. TBOA (20 ng in 1l of ACSF)
was injected under deep anesthesia into the right lateral ventricle
of P5 rats (see Materials and Methods). The animals were then
monitored by videotape. This treatment consistently generated
in 12 of 13 pups recurrent stereotyped seizures during a period of
2 hr after the injection (see supplemental video at http://www.
inmed.univ-mrs.fr/resources/Demarque2004.avi). Immediately
after arousal, the animals displayed myoclonus of anterior or
posterior limbs, followed by a tonic extension of the four limbs
frequently associated with head bobbing. This type of seizure
occurred every 3–7 min and lasted for 30 –90 sec. Animals in-
jected with the vehicle alone (n  4) did not display seizures.
Parallel injections of APV (15 ng in 1 l) fully prevented the
effects of TBOA, because the pups either showed no seizures (n
6 of 8 pups) or displayed a single episode during the 2 hr after the
injection (n 2 of 8 pups). Therefore, in vivo, reduction of glu-
tamate transporter activity generates seizures through the activa-
tion of NMDA receptors. These seizures are reminiscent of those
reported by Kabova et al. (1999) with direct intraperitoneal in-
jection of NMDA.
Discussion
Our results suggest that high-affinity glutamate transporters play
an important role in the regulation of intercellular communica-
tion at an early developmental stage when neurons have few func-
tional synapses. In vitro, blockade of the transporters persistently
altered the ongoing neuronal activity and replaced it with SOs.
SOs are network-driven events and are associated with Ca 2 os-
cillations in the entire neuronal population. They are triggered by
glutamate and by activation of NMDA receptors. In vivo, block-
ade of glutamate transporters generates seizures also triggered by
NMDA receptor activation. Thus, the early function of glutamate
transporters is an important developmental feature that allows
the expression of physiological activities while preventing abnor-
mal synchronization of neuronal activities and seizures.
Mechanism of TBOA-generated SOs
The activation of NMDA receptors is a central feature in the
synchronization of the maturing network, because SOs are fully
blocked by NMDA receptor antagonists and bath application of
NMDA produces oscillations. Furthermore, SOs and NMDA-
induced oscillations share similar pharmacological properties,
including their sensitivity to TTX but not to intracellular block-
ade of Na channels. This indicates that oscillations are driven by
the network and not by intrinsic oscillatory mechanisms. This
contrasts with the effect of the sustained NMDA receptor activa-
tion reported in other studies (Hu and Bourque, 1992; Tell and
Jean, 1993; Hochmann et al., 1994). Thus, the mechanism leading
Figure 3. NMDA generates synchronous network-driven oscillations. A1, Bath application of NMDA (10M) generated current
oscillations (top traces) associated with extracellular activities (bottom traces). At 30M, NMDA generated a large inward current
but no oscillations. A2, Magnification of the three intracellular and extracellular recordings indicated by letters in A1. B, Oscillations
recorded in the current-clamp mode. C, Oscillations recorded at a different membrane potential with a pipette filled with KM2SO4.
D, E, Oscillations were blocked by CNQX and TTX but not by bicuculline.
Figure 4. SOs are generated in the entire intact neocortex. A, Photograph of the experimen-
tal device. The entire cortex of one hemisphere from a P5 rat is placed in the recording chamber
with the three recording electrodes. The whole-cell pipette (W.C.) is in the occipital cortex, the
extracellular electrode E.C1 is in the frontal cortex, and E.C2 is in the parietal cortex. B1, Bath
application of TBOA-induced SOs at the three recordings sites. These oscillations were blocked
by the addition of D-APV. B2, Magnification of two sets of oscillations. Note that SOs could be
initiated in any cortical region and occurred in the three regions within the seconds range.
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to the synchronization of the network we describe would involve
an elevation of extracellular glutamate concentration and the ac-
tivation of synaptic (and possibly extrasynaptic) NMDA recep-
tors leading to the generation of bursts of action potentials. These
bursts may in turn lead to the release of glutamate and the acti-
vation of glutamate receptors of target neurons. Mechanisms im-
plicated in the generation of the oscillatory pattern remain to be
clarified. A periodic desensitization of NMDA receptors is un-
likely because applications of higher concentrations of TBOA or
NMDA generated a long-lasting inward current. We propose that
SOs are triggered by a cyclic modulation of glutamate levels in the
extracellular space by mechanisms that could include: (1) a pre-
synaptic inhibition of the release of glutamate (MacDermott et
al., 1999); (2) a transient release of glutamate by the reversal of
transporters unaffected by TBOA (30 M). This reversion may
occur as a consequence of a sustained uptake and the dissipation
of electrochemical gradients (Danbolt, 2001); or (3) a cyclic pat-
tern of glutamate release. Glial cells may contribute to this pattern
because they display spontaneous Ca 2 oscillations with fre-
quency and duration in the range of SOs and they release gluta-
mate (for review, see Auld and Robitaille, 2003).
TBOA induces epilepsy
There is abundant, but quite contradictory, literature concerning
the possible role of transporters in the epilepsies. Thus, in surgical
resections from human epileptic structures as well as in animal
models, an increase or a decrease of transporter expression has
been reported (Meldrum et al., 1999; Crino et al., 2002; Proper et
al., 2002). Experiments using knock-out mice for transporters or
chronic treatment with antisense have also led to conflicting ob-
servations because in some studies, but not others, seizures were
generated. Thus, GLT1 knock-out mice display spontaneous re-
current seizures or are more susceptible to pentamethylenetetra-
zole, which has been explained by an elevation of extracellular
glutamate concentration (Tanaka et al., 1997), whereas chronic
administration of antisense nucleotide of GLT1 or GLAST in
adult rats produced elevated extracellular levels of glutamate as-
sociated with excitotoxicity but not seizures (Rothstein et al.,
1996). These contradictory results also applied to the neuronal
EAAC1 transporter [i.e., whereas nucleotide antisense treatment
resulted on epileptic seizures as a possible consequence of a de-
crease in GABA synthesis (Sepkuty et al., 2002), the EAAC1
knock-out mice have a reduced spontaneous locomotor activity
but do not develop seizures (Peghini et al., 1997)]. Also, cortical
or hippocampal slices obtained from these mice did not show
synchronous network activity that is the hallmark of epilepsy. In
the present study, we used an acute treatment that reduces the
three main transporters. Our data suggest that seizures observed
in vivo are related to the blockade of transporters and to SOs that
may represent ictal-like activity. Thus, (1) the clinical manifesta-
tion is immediate, like the generation of SOs observed in slices or
in the entire neocortex, (2) the range of SO duration matches the
seizure manifestation observed in vivo, (3) SOs are observed in all
cortical areas and are generalized like seizures, and (4) SOs and
seizures are blocked or prevented by APV. Our data also indicate
that the synchronization of network activity and seizures may not
be related to a decrease of GABA synthesis or GABA efficiency
(Sepkuty et al., 2002) because an increase of spontaneous PSCs
was observed during SOs that were also resistant to bicuculline. A
fundamental property of the developing network is its capacity to
oscillate (Ben-Ari, 2001), and the accumulation of glutamate that
results from blockade of transporters leads to the activation of
NMDA receptors and the synchronization of networks. These
combined factors underlie the low threshold of seizure genera-
tion in the developing cortex. Therefore, dysfunction of gluta-
mate transporters and the resulting increase of glutamate may
play an important role in infantile epilepsies possibly by the acti-
vation of NMDA receptors. Additional studies are required to
evaluate the clinical relevance of these observations in view of the
excitotoxicity produced by the activation of NMDA receptors
and the apoptotic damage produced by NMDA receptor antago-
nists (Ikonomidou et al., 1999; Olney, 2002).
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